期刊文献+

p53、p21^(ras)蛋白和P-糖蛋白在胃癌中过表达的意义 被引量:4

Clinical significance of over-expression of p53,p21^(ras) protein and P-glycoprotein in gastric carcinoma
下载PDF
导出
摘要 目的 :研究胃癌组织p5 3、p2 1 ras蛋白和P 耐药糖蛋白 (P gp)在胃癌中的表达及临床意义。方法 :采用免疫组化SABC法检测 7例正常胃粘膜、1 2例慢性萎缩性胃炎、8例粘膜慢性胃炎伴肠型不典型增生和 93例胃腺癌组织中p5 3、p2 1 ras蛋白和P gp的表达。结果 :p5 3、p2 1 ras蛋白和P gp在正常胃粘膜组、癌前病变组和胃腺癌组中的阳性率分别为 0 ,1 4 3% ,0 ;2 0 0 % ,2 5 0 % ,5 0 % ;5 5 9% ,5 1 6 % ,4 4 1 %。p5 3蛋白、P gp表达均与淋巴结转移有关 (P <0 0 5 ) ;p2 1 ras蛋白表达与肿瘤的浸润程度有关 (P <0 0 5 ) ;P gp表达与p5 3和p2 1 ras表达有显著的协同性 (P <0 0 5 )。结论 :p5 3和p2 1 ras蛋白常并存于胃癌组织中。p5 3突变蛋白和P gp过表达在胃癌淋巴结转移中起重要作用 ,因此早期进行p5 3蛋白和P Objectives:To study the levels of p53,p21 \{ras\} protein and P glycoprotein(P gp) in tissues of gastric carcinoma tissues and its clinical significance.Methods:20 cases of gastric precancerous lesions and 93 adenocarcinomas and 7 normal control tissues were analyzed for p53,p21 \{ras\} and P gp by immunohistochemical staining.Results:The positive expressions of p53,p21 \{ras\} and P gp in normal,precancerous and adenocarcinomas were 0,14 3%,0;20 0%,25 0%,5 0%;and 55 9%,51 6%,44 1%,respectively.A significant correlation was found that both p53 and P gp overexpression were related to lymph node metastasis(P<0 05).p21 \{ras\} protein was also correlated to invasiveness(P<0 05),Conclusions:There are commonly co expression of p53 mutational protein,p21 \{ras\} protein and P gp in the tissues of gastric carcinoma.p53 and P gp overexpression may play an important role in the lymph node metastasis of gastric cancer,so that p53 and P gp gene products immunostaining assay at the early stage of gastric cancer may be of great clinical significance.
出处 《广西医学》 CAS 2003年第7期1107-1109,共3页 Guangxi Medical Journal
关键词 胃癌 P53基因 P21RAS蛋白 P-耐药糖蛋白 免疫组织化学 Gastric neoplasm P glycoprotein p53 protein p21 protein
  • 相关文献

参考文献11

  • 1梁建昌,田伏洲,马宏敏.胃癌基因表达的免疫组化研究[J].临床与实验病理学杂志,1995,11(4):269-271. 被引量:7
  • 2郝莹,张锦坤,吕有勇,易粹琼.应用多种方法检测胃癌演变过程中ras基因的突变[J].中华内科杂志,1997,36(9):595-598. 被引量:16
  • 3Leonardo E, Valente G, Cappia S, et al. Immunohistochemical evaluation of P-glycoprotein in human malignancies by monoclonal antibody MC57.Int J Cancer 1994;57(6) :841.
  • 4Weinstein RS, Kusyak JR, Kluskens LF, et al..P-glycoprotein in pathology: the multidrug resistance gene family in humans. Hum Pathol 1990;21(1):24.
  • 5Decker DA, Morris LW, Levine AJ, et al. Immunohistochemical analysis of P-glycoprotein expression in breast cancer, clinical correlations. Ann Clin Lab Sci 1995;25(1):52.
  • 6Beroud C, Soussi T. p53 gene mutation:software and database.Nucleic Acids Res 1998;26(2) :200.
  • 7Porter PL,Gown AM,Kramp SG,et al. Widespread p53 overexpression in human malignant. Am J Pathol 1992;140(2) :145.
  • 8Benhattar J, Cerottinig JP, Saraga E, et al. p53 mutations as a possible predictor of response to chemotherapy in metastatic colorectal carcinomas, Int J Cancer 1996;69(3):190.
  • 9Chin K-V, Ueda K, Pastan I, et al. Modulation of the activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992;255(5043) :459.
  • 10Lacueva FJ, Calpena R, Medrano J, et al. Changes in P-glycoprotein expression in gastric carcinoma with respect to distant gastric mucosa may be influenced by 1353. Cancer 2000; 89 ( 1 ) :21.

二级参考文献1

  • 1Deng G R,Oncogene Res,1991年,6卷,33页

共引文献21

同被引文献47

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部